Wound care company sees potential in regenerative medicine

02/9/2011 | Today's Wound Clinic magazine

Advanced BioHealing makes Dermagraft -- a wound care product that contains living human fibroblast cells, an extracellular matrix and an absorbable scaffold -- which is approved to treat diabetic foot ulcers and is in clinical trials for healing venous leg ulcers, Senior Vice President Dean Tozer said. "This approach to healing wounds is a prime example of the potential of the emerging field regenerative medicine," Tozer said in this interview with Today's Wound Clinic. The company also developed a community health education program to raise awareness about diabetic foot ulcers.

View Full Article in:

Today's Wound Clinic magazine

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC